Sc++ Citations (2)
Originally described in: An engineered ScCas9 with broad PAM range and high specificity and activity.Chatterjee P, Jakimo N, Lee J, Amrani N, Rodriguez T, Koseki SRT, Tysinger E, Qing R, Hao S, Sontheimer EJ, Jacobson J Nat Biotechnol. 2020 May 11. pii: 10.1038/s41587-020-0517-0. doi: 10.1038/s41587-020-0517-0. PubMed Journal
Articles Citing Sc++
| Articles |
|---|
PAM-flexible genome editing with an engineered chimeric Cas9.
Zhao L, Koseki SRT, Silverstein RA, Amrani N, Peng C, Kramme C, Savic N, Pacesa M, Rodriguez TC, Stan T, Tysinger E, Hong L, Yudistyra V, Ponnapati MR, Jacobson JM, Church GM, Jakimo N, Truant R, Jinek M, Kleinstiver BP, Sontheimer EJ, Chatterjee P.
Nat Commun. 2023 Oct 4;14(1):6175. doi: 10.1038/s41467-023-41829-y.
PubMed
Associated Plasmids |
| Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. Zhu W, Du W, Rameshbabu AP, Armstrong AM, Silver S, Kim Y, Wei W, Shu Y, Liu X, Lewis MA, Steel KP, Chen ZY. Sci Transl Med. 2024 Jul 10;16(755):eadn0689. doi: 10.1126/scitranslmed.adn0689. Epub 2024 Jul 10. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.